Literature DB >> 8598104

VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma.

J L Pittet1, P de Moerloose, G Reber, C Durand, C Villard, N Piga, D Rolland, S Comby, G Dupuy.   

Abstract

VIDAS D-dimer (bioMérieux) is a new quantitative ELISA for D-dimer determination designed for the VIDAS automated system. The test contains single-dose, ready-to-use reagents and is completed within 35 min. Quantitative results are obtained from a calibration curve stored in the software of the system and expressed as fibrinogen equivalent units. The two-step capture/tag test relies on two complementary monoclonal anti-D-dimer antibodies, the second one being labeled with alkaline phosphatase. The upper limit of the measuring range is 1000 micrograms/L and the lower detection limit is <50 micrograms/L, which is below the lower limit of the reference interval (68-494 micrograms/L). Reproducibility (CV) within and between runs ranges from 5% to 7%. There is no interference from heparin, bilirubin, hemoglobin, fibrinogen degradation products, or plasma turbidity. Comparison with a conventional ELISA (y) gave good correlation (r= 0.91, n= 579) and comparable results (y= 1.35x - 148, S(y/x)= 750), especially for D-dimer concentrations ranging from 0 to 1000 micrograms/L (y= 1.09x - 10.6, r= 0.88, S(y/x)= 170).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598104

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

Review 1.  Diagnosis, investigation, and management of deep vein thrombosis.

Authors:  Clive Tovey; Suzanne Wyatt
Journal:  BMJ       Date:  2003-05-31

2.  Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Authors:  Hideki Nomura; Hideo Wada; Toshiro Mizuno; Naoyuki Katayama; Yasunori Abe; Maki Noda; Kaname Nakatani; Takeshi Matsumoto; Satoshi Ota; Norikazu Yamada; Akihiro Sudo; Atsumasa Uchida; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-02-19       Impact factor: 2.490

3.  Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.

Authors:  Marc A Rodger; Susan R Kahn; Philip S Wells; David A Anderson; Isabelle Chagnon; Grégoire Le Gal; Susan Solymoss; Mark Crowther; Arnaud Perrier; Richard White; Linda Vickars; Tim Ramsay; Marisol T Betancourt; Michael J Kovacs
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

4.  Diagnostic value of D-dimer measurement in patients referred to the emergency department with suspected myocardial ischemia.

Authors:  Giuseppe Lippi; Luca Filippozzi; Martina Montagnana; Gian Luca Salvagno; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2007-06-01       Impact factor: 2.300

5.  Verification of automated latex-enhanced particle immunoturbidimetric D-Dimer assays on different analytical platforms and comparability of test results.

Authors:  Ivana Lapić; Désirée Coen Herak; Snježana Prpić; Andrea Prce; Vanja Raščanec; Renata Zadro; Dunja Rogić
Journal:  Biochem Med (Zagreb)       Date:  2020-10-15       Impact factor: 2.313

6.  Analytical performance of a new immunoturbidimetric D-dimer assay and comparison with available assays.

Authors:  Laurie Talon; Virginie Fourneyron; Alexandre Trapani; Bruno Pereira; Thomas Sinegre; Aurélien Lebreton
Journal:  Res Pract Thromb Haemost       Date:  2022-02-06

7.  Point of care D-dimer testing in the emergency department: a bioequivalence study.

Authors:  Shuhana Perveen; Danielle Unwin; Amith Loknath Shetty
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.